Drug Pipeline

JS207 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07503756 JS212 Combination Therapies in Metastatic Colorectal Cancer Metastatic Colorectal Cancer Recruiting
NCT06868836 Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in… Non-squamous Non-small Cell Lung Cancer Recruiting
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… Breast Neoplasm Recruiting
Phase 1/2
NCT07466160 A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors Solid Tumor Recruiting
Sponsors Running JS207 Trials
Shanghai Junshi Bioscience Co., Ltd. (2) Fudan University (1) Mabwell (Shanghai) Bioscience Co., Ltd. (1)
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1) HER2-Positive Breast Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Colorectal Cancer (1)
Get alerts when JS207 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free